comparemela.com

Latest Breaking News On - Jubilant pharma ltd - Page 1 : comparemela.com

Stock that will see action today: 25 April 2024 - The Hindu BusinessLine

Stock that will see action today: 25 April 2024 - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Japan
Hyderabad
Andhra-pradesh
India
United-states
Hindustan
India-general
Jolarpettai
Tamil-nadu
Prateek-agrawal
Navin-agarwal
Anuradha-razdan

The Radiopharmaceuticals Market to grow by USD 4.61 billion from 2022 to 2027, North America is estimated to contribute 42% to the growth

/PRNewswire/ The radiopharmaceuticals market is expected to increase by USD 4.61 billion, at a CAGR of 10.22% from 2023 to 2027. North America is estimated.

United-kingdom
United-states
America
Jesse-maida
Prnewswire-theradiopharmaceuticals
Company-landscape
Positron-corp
Radiomedix-inc
Bayer-ag
Pharmalogic-holdings-corp
Company-analysis
Lantheus-holdings-inc

Jubilant unit makes over five-fold gain by selling stake in US firm

Jubilant Pharma Ltd, a Singapore-based subsidiary of Mumbai-listed Jubilant Pharmova Ltd, will sell its entire stake in a US company as part of a larger ..

Singapore
Jubilant-pharma-ltd
Jubilant-life-sciences-ltd
Sofie-biosciences-inc
Jubilant-pharmova-ltd
Pharma-ltd
Mumbai-listed-jubilant-pharmova-ltd
Trilantic-capital
Subscribe-now
Jubilant-life-sciences
Jubilant-pharmova-limited

Stocks that will see action today: January 29, 2023 - The Hindu BusinessLine

Stocks that will see action today: January 29, 2023 - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Baroda
Gujarat
India
Mumbai
Maharashtra
Waluj
Pune
Bengaluru
Karnataka
Singapore
Garbham
Andhra-pradesh
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.